Latest filing published 20 Apr 2026 for Milestone Pharmaceuticals Inc., €6,469.
Joseph Gerard Oliveto appears in our data through filings on Milestone Pharmaceuticals Inc. shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 13 May 2019 to 16 April 2026.
The open-market record consists of 9 sales worth €111k, with no purchase. Besides market trades, the filings include 1 option exercise. So far in 2026, the count stands at no purchases and 9 sales.
On 20 April 2026 came the latest disclosure, an open-market sale for €6,469 in Milestone Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations